Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03969160
Other study ID # 2017/419
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 11, 2017
Est. completion date February 22, 2018

Study information

Verified date May 2019
Source Uppsala University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study explores the brain basis of imaginal exposure, a widely used psychological treatment technique. Specifically, this study uses functional magnetic resonance imaging to examine brain areas activated during imaginal exposure, in individuals fearful of spiders. Physiological responses and subjective fear experienced during imaginal exposure are also assessed.

The primary aim of this study is to explore differences in neural activity during exposure to phobic, compared to neutral, mental imagery. The study will focus primarily on exploratory whole brain analyses, but will also include regions of interest analyses on brain areas previously associated with imaginal exposure. The experimental procedure consists of repeated exposure to mental imagery, i.e. imagery of short durations, including either highly emotion-provoking or neutral content, prompted by verbal instructions. A secondary aim is to explore the effects of repeated exposure to mental imagery, used during the experimental procedure, on subjective fear and physiological responses.


Description:

Results will elucidate if neural activity to phobic imagery differs from activity associated with the production of mental imagery per se. Findings will also increase our general understanding of the neural basis of imaginal exposure treatments.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date February 22, 2018
Est. primary completion date February 14, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Significant fear of spiders

Exclusion Criteria:

- Current psychiatric disorder other than spider phobia

- Substance abuse

- Neurological disease

- Psychological treatment or psychotropic medication within six months

- Magnetic resonance imaging contradiction

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Imaginal exposure
Imaginal exposure to mental imagery of phobic and neutral stimuli

Locations

Country Name City State
Sweden Uppsala University Hospital - Akademiska sjukhuset Uppsala
Sweden Uppsala University, Departement of Psychology Uppsala

Sponsors (1)

Lead Sponsor Collaborator
Uppsala University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Spider Phobia Questionnaire (SPQ) SPQ is a self-rated questionnaire assessing fear of spiders. A high score in SPQ (>19) is required for inclusion in the study. Recruitment
Other Spielberger State-Trait Anxiety Inventory (STAI-T) STAI-T is a self-rated questionnaire assessing trait anxiety and is included to describe the sample in terms of anxiety proneness. High scores indicate higher levels of trait anxiety (range, total score: 20 - 80) Day 1
Other Number of intrusive mental imagery of phobic stimuli Number of intrusive mental images of phobic stimuli recorded by participants in a diary, daily (morning, afternoon, evening and night) for 7 days. This measure is included as a manipulation check. 7 days, starting on day 1.
Other Demand questions Two questions asking participants' to appreciate the emotional impact of producing mental imagery versus focusing on the verbal aspects of phobic situations used in the experimental procedure. This measure is included as a manipulation check. Day 1
Other The Plymouth Sensory Imagery Questionnaire (Psi-Q) The Psi-Q is a self-rated measure of vividness of imagery across different sensory modalities. Higher scores indicate higher levels of vividness (range, total score 0 - 70). Day 1
Primary Blood oxygen level dependent contrast (BOLD-signal) BOLD-signal is assessed using functional magnetic resonance imaging. Day 1
Primary Physiological response during exposure to mental imagery Skin-conductance responses are used as a measure of physiological response. Day 1
Secondary Physiological response during exposure to mental imagery Skin-conductance responses are used as a measure of physiological response. Follow-up (one week after day 1)
Secondary Differences in physiological response during exposure to mental imagery, during day 1 compared to the follow-up session. Skin-conductance responses are used as a measure of physiological response. Difference between day 1 and the follow-up session (one week after day 1)
Secondary Ratings of subjective fear participants' expect to experience during exposure to mental imagery Scale: 0-100; no fear at all - extreme fear. Day 1
Secondary Ratings of subjective fear experienced during exposure to mental imagery Scale: 0-100; no fear at all - extreme fear. Fear ratings are completed immediately after the imaginal exposure experimental procedure Day 1
Secondary Spielberger State-Trait Anxiety Inventory (STAI-S) STAI-S is a self-rated questionnaire included to assess state-anxiety experienced during exposure. High scores indicate high levels of state anxiety (range, total score: 20 - 80). Day 1
Secondary Differences in ratings of subjective fear during exposure to mental imagery, during day 1 compared to the follow-up session. Scale: 0-100; no fear at all - extreme fear. Difference between day 1 and the follow-up session (one week after day 1)
Secondary Vividness of mental imagery Vividness of mental imagery of phobic stimuli (scale: 1-5; no image at all - image as clear and vivid as real life). Day 1
Secondary Vividness of mental imagery Vividness of imagery of phobic stimuli (scale: 1-5; no image at all - image as clear and vivid as real life). Follow-up (one week after day 1)
Secondary Differences in vividness of mental imagery, during day 1 compared to the follow-up session. Vividness of imagery of phobic stimuli (scale: 1-5; no image at all - image as clear and vivid as real life). Difference between day 1 and the follow-up session (one week after day 1)
Secondary Difficulties in emotion regulation scale (DERS) DERS is a self-rated questionnaire, included to explore potential relations between imaginal exposure and difficulties in emotion regulation. High scores indicate more difficulties in emotion regulation (range, total score: 36 - 180) Day 1